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Abstract
The number of new psychoactive substances (NPS) is constantly increasing. However, although
the number might be large, most NPS have a low prevalence of use, so keeping screening librar-
ies updated with the relevant analytical targets becomes a challenge. One way to ensure sufﬁcient
screening coverage is to use shared high resolution-mass spectrometry (HR-MS) databases, such
as HighResNPS.com: a free, online, spreadsheet-format, crowd-sourced HR-MS database for NPS
screening. The aims of this study were (i) to present the database to the scientiﬁc community and
(ii) to verify that the HighResNPS database can be utilized in suspect screening workﬂows for LC–
HR-MS instruments and software from four different instrument vendors. A sample was spiked
with 10 NPS, and participating laboratories then analyzed the sample with their respective HR-MS
vendor platforms and the HighResNPS database. The HighResNPS data were obtained via a
spreadsheet converted to ﬁt the import speciﬁcations of the different vendor platforms. Suspect
screening was performed using LC–HR-MS vendor platforms from Thermo Fisher, Waters, Bruker
and Agilent. All 10 NPS were identiﬁed in at least three workﬂows used for the four different ven-
dor platforms. Multiple users have submitted data to HighResNPS for the same NPS, which
resulted in multiple true-positive identiﬁcations for these NPS. Suspect screening with LC–HR-MS
can be based on diagnostic fragment ions reported by users of different vendor platforms and can
support NPS identiﬁcation in biological samples and/or seizure analyses when no reference stan-
dard is available in-house. The present work clearly demonstrates that HighResNPS data is com-
patible with instruments and screening software from at least four different vendor platforms. The
database can thus serve as a useful add-on in LC–HR-MS screening workﬂows.
Introduction
The emergence of new psychoactive substances (NPS) on the drug
market is of great concern for forensic and clinical laboratories
alike. Large numbers of NPS enter the market every year (1), and
their time on the market is often short, as they can readily disappear
when they are banned (2). Moreover, the prevalence of use can be
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quite low when compared with the traditional drugs of abuse (1).
As of the end of 2017, the European monitoring center for drugs
and drug addiction was monitoring 670 NPS. A group of particu-
lar concern at the moment is the fentanyl analog group, which has
been associated with 250 deaths in Europe in 2016–2017 (1, 3).
Screening of biological samples for NPS can require the use of mul-
tiple analytical targets, depending on the route of administration
and the distribution, metabolism and excretion proﬁle of the given
NPS. Certain synthetic cannabinoids are not detected in unchanged
form in urine, which means that the metabolites need to be added
to the screening libraries (4, 5). Analytical reference materials are
usually not immediately available after a NPS enters the market,
although the reference material providers are focusing on reducing
this time gap. On the other hand, purchasing costly reference mate-
rial for around 100 NPS and their metabolites every year is hard to
justify in a laboratory with limited funds and/or few NPS cases per
year.
A common approach to address NPS in forensic laboratories is
qualitative screening for this group of compounds, either using gas
chromatography–mass spectrometry or liquid chromatography–
high-resolution mass spectrometry (LC–HR-MS) (6–9). Gas chro-
matography–mass spectrometry and LC–HR-MS are suitable for
screening of biological samples and/or seized materials, as analyti-
cal data can be compared with MS libraries covering thousands of
analytical targets. Free HR-MS databases of relevance to forensic
applications include MassBank (10), mzCloud1, HMDB (11) and
orbitrap-based commercially available libraries (12). Also worth
mentioning are the two online data repositories, NPS Data Hub
(13) and the RESPONSE database2, which provide a wide range of
analytical data on NPS. All these databases provide high-quality
MS data, but the coverage of NPS varies and the data are not read-
ily transferable for suspect screenings on HR-MS equipment from
different vendors. Different HR-MS/MS instruments tend to gener-
ate comparable diagnostic fragment ions after collision-induced
fragmentation (14), which is a prerequisite for using shared data-
bases. HR-MS databases based on diagnostic fragment ions are
less dependent on instrument- and method-speciﬁc variables, when
compared with mass spectral databases. Furthermore, analytical
equipment and data at modern forensic laboratories are occasion-
ally operated ofﬂine to protect sensitive data, which reduces the
suitability of data acquired from forensic HR-MS equipment for
cloud-based data analyses. Therefore, these databases should be
downloadable.
These obstacles led a group of researchers to initiate the
HighResNPS3 database. Their intention was to help in keeping HR-
MS screening libraries updated with analytical information from the
moment a speciﬁc NPS becomes available to a given participating
laboratory. The HighResNPS database currently has active users
from at least 10 laboratories.
The aims of the present study were to illustrate how the
HighResNPS database can be implemented as a part of HR-MS
screening workﬂows using instrumental setups from four different
HR-MS vendors. A mixture of 10 NPS was analyzed on four differ-
ent instruments from different instrument vendors. We also explain
the intention behind the database and describe its structure.
Methods and Experimental
Materials and reagents
Deschloro-ketamine, ﬂuoropentedrone, 3-methylphenmetrazine, 2C-
B-FLY, adinazolam, acrylfentanyl, bk-IVP, 25-NBP, CUMYL-4CN-
BINACA and MDMB-CHMICA were obtained from seizures sent
to the Section of Forensic Chemistry at the University of
Copenhagen for analysis or kindly provided by the Slovenian
National Forensic Laboratory. All solvents used in the preparation
of mobile phases were of LC–MS grade.
Database concept
The initial HighResNPS format was a spreadsheet shared in a
Dropbox folder among Nordic forensic laboratories that used HR-
MS screening as a part of their routine toxicological analysis. The
spreadsheet format allows data transfer to screening software from
different vendors, and the data can easily be adjusted to the research
question at hand. However, the shared-spreadsheet format quickly
proved insufﬁcient as the number of users increased. An online data-
base was developed with the intention of having it serve as a free,
crowd-sourced database of experimental HR-MS data that members
can use in their respective HR-MS screening methods. Upon obtain-
ing a login to the site, the user is encouraged to provide analytical
data on at least ﬁve NPS per year. The user ﬁrst deﬁnes the analyti-
cal instrumentation and method they use, based on the template
shown in Figure 1. The database is intended to run with limited con-
tinuous data curation. When data on the same compound are shared
from different laboratories with different analytical setups, as exem-
pliﬁed for MDMB-CHMICA in Table I, the multiple entries can
serve to self-validate the analytical data. The users can also use the
database to see which laboratories have a stock, seizure or knowl-
edge of a certain NPS.
The data analyzed in this study were obtained from www.
HighResNPS.com. The following licenses/restrictions apply: The
user needs a log-in, which is available upon request. Requests to
access these datasets should be directed to P.W.D., petur.dals-
gaard@sund.ku.dk.
Data format
The HR-MS data in HighResNPS are described via the molecular
formulas and exact masses for the precursor ion and 0–3
Figure 1. LC–HR-MS method speciﬁcations from highresNPS.com.
1 https://www.mzcloud.org/ (accessed December 19, 2018).
2 https://www.policija.si/apps/nﬂ_response_web/seznam.php
(accessed December 19, 2018).
3 URL: www.HighResNPS.com (accessed January 3, 2019).
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Table I. Selected data from HighResNPS.com on the synthetic cannabinoid MDMB-CHMICA with analytical data from ﬁve different participating laboratories. “0”: No value reported or not acquired
ID Compound RT PMF Pmass F1MF F1mass F2MF F2mass F3MF F3mass originName LAB Country Method Owner Comment InChIKey IUPAC name
238 MDMB-
CHMICA
8.15 C23H32N2O3 385.2486 C16H18NO 240.1383 C23H32
N2NaO3
407.2299 0 RESPONSE Aarhus Denmark Bruker 3 M.F.A. SRJKCVHW-
IDFUBO-
HXUWFJ-
FHSA-N
N-[[1-(cyclohexylmethyl)-
1H-indol-3-yl]carbonyl]-
3-methyl-valine, methyl
ester
175 MDMB-
CHMICA
6.18 C23H32N2O3 385.2486 C16H18NO 240.1383 C9H6NO 144.0444 0 Seizure Trondheim Norway Agilent 3 Per Ole
Gundersen
SRJKCVHW-
IDFUBO-
HXUWFJ-
FHSA-N
N-[[1-(cyclohexylmethyl)-
1H-indol-3-yl]carbonyl]-
3-methyl-valine, methyl
ester
354 MDMB-
CHMICA
0 C23H32N2O3 385.2486 C16H18NO 240.1383 0 0 Theoretical Copenhagen Denmark Thermo 2 Petur
Dalsgaard
Predicted
fragments
SRJKCVHW-
IDFUBO-
HXUWFJ-
FHSA-N
methyl (2S)-2-{[1-
(cyclohexylmethyl)-1H-
indol-3-yl]formamido}-
3,3-dimethylbutanoate
637 MDMB-
CHMICA
0 C23H32N2O3 385.2486 0 0 0 EMCDDA Copenhagen Denmark No method Petur
Dalsgaard
From
EMCDDA
list
SRJKCVHW-
IDFUBO-
HXUWFJ-
FHSA-N
methyl (S)-2-(1-
(cyclohexylmethyl)-1H-
indole-3-carboxamido)-
3,3-dimethylbutanoate
1190 MDMB-
CHMICA
(MMB-
CHMINACA)
11.96 C23H32N2O3 385.2486 C16H18NO 240.1383 C9H6NO 144.0444 C8H6N 116.0495 Standard Labor Krone Germany Waters
Forensic
Toxicology
Screening
Ronald Agius SRJKCVHW-
IDFUBO-
HXUWFJ-
FHSA-N
methyl (S)-2-(1-
(cyclohexylmethyl)-1H-
indole-3-carboxamido)-
3,3-dimethylbutanoate
1489 MMB-
CHMINACA
12.43 C23H32N2O3 385.2486 C16H18NO 240.1383 C9H6NO 144.0444 C4H7 55.0542 Standard University of
Athens
Greece Brukers
Pesticide
Screener
Nikos
Thomaidis
SRJKCVHW-
IDFUBO-
HXUWFJ-
FHSA-N
methyl (S)-2-(1-
(cyclohexylmethyl)-1H-
indole-3-carboxamido)-
3,3-dimethylbutanoate
EMCDDA, European monitoring center for drugs and drug addiction; F1MF, fragment 1 molecular formula; F1mass, fragment ion 1 exact mass; ID, automatically generated unique item number; InChIKey, International chemical identiﬁed key; IUPAC name, “International union of pure and applied
chemistry” name; LAB, laboratory; Pmass, parent exact mass; PMF, parent molecular formula; RT, retention time.
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diagnostic fragment ions. The simplicity of the database format
makes it compatible with a wide range of screening software. The
nomenclature for NPS is not always rational and consistent, as
illustrated with MDMB-CHMICA, which is also known as MMC-
CHMINACA. To solve the problem with inconsistent naming con-
ventions and type errors, users are encouraged to include the
InChIKey as a structure-speciﬁc identiﬁer, which allows the auto-
matic generation of hyperlinks for a Google search, thereby
enabling further information retrieval. Users are also encouraged
to include the IUPAC name in the submission, which can be con-
verted into a molecular structure and used for validation of the
InChIKey. Data on the laboratory and analysis method link to
unique entries, as deﬁned below. Additional metadata include the
owner, origin of the compound, and drug class based on the classi-
ﬁcation used on EDND: the European information system and
database on new drugs.4 NPS are not a well-deﬁned chemical
group; therefore, no exclusion criteria have been deﬁned for entries
in the database.
The database contains two search boxes: one for text queries
and one for mass queries. Compounds can be searched by full or
partial (e.g., “fenta”) names, and the mass search ﬁeld can search
across precursor and fragment ions. Alternatively, the database
content can be exported to a spreadsheet and further manipulated.
The exported ﬁle can then either be handled in Microsoft Excel or
converted to text-based formats for further handling in other
programs.
Adding data
The contributor adds data using the template in Figure 2, which
consists of the name, retention time, and molecular formulas, as
well as the exact mass calculated from the molecular formula and
compared with the measured accurate mass. Fragment ions can be
selected from a drop-down list of commonly observed diagnostic
fragment ions. If the experimentally determined fragment ions are
not on the drop-down list, the data should be typed in manually.
The origin of the injected analyte should be stated, as well as the
contributing laboratory and which of the deﬁned methods were
used. To whatever extent possible, the drug class, InChIKey and
IUPAC should be added; however, this is not always possible for
tentatively identiﬁed metabolites. Following the data addition, the
contributor is encouraged to upload pictures of the mass spectrum.
Application in forensic workﬂows
The direct applicability of HighResNPS in forensic screening was
veriﬁed by conducting a test using four instruments to provide an
example of how the database can be utilized with different screening
software. A selection of 10 NPS from seized materials, which cov-
ered some of the main NPS groups, were mixed and then screened
on four LC–HR-MS instruments. The NPS mixture was shipped out
as a methanolic extract of around 1 μg/mL, and the sample was ana-
lyzed without dilutions or other sample preparation for all instru-
ments. A brief overview of each instrument setting is given in
Table II, and the data analysis workﬂow is given in Thermo Fisher
TraceFinder, Waters UNIFI, Bruker data analysis and Agilent
MassHunter. The participants were requested to abstain from using
Figure 2. Data entry for acrylfentanyl with analytical mass spectral data and compound identiﬁers.
4 URL: https://ednd.emcdda.europa.eu (accessed December 19, 2018).
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additional information beyond the diagnostic fragment ions in
HighResNPS, to use only one diagnostic fragment ion as the identiﬁ-
cation criterion, and to allow multiple identiﬁcations per peak if
relevant.
The exported data from the HighResNPS spreadsheet was ﬁrst
reduced by ﬁltering out entries without fragment ions. The resulting
data were then applied for suspect screening on the respective LC–
HR-MS(/MS) equipment and screening software.
Thermo Fisher TraceFinder
A TraceFinder database was developed based on the HighResNPS
spreadsheet. All entries were renamed to [name@item number] to
allow identiﬁcations based on analytical data from multiple entries.
Retention time was set to 9min ± 540 s (the entire run) to allow
identiﬁcation from precursor and fragment ions alone. A master
method was then created with the following processing parameters
for identiﬁcation: mass error MS1, 5 ppm; mass error fragment ions,
10 ppm; and at least one fragment ion. Retention time and isotopic
match were not used as identiﬁcation criteria. The acquired data
ﬁles were then processed with the developed master method.
Waters UNIFI
A UNIFI database (Scientiﬁc Library) was created based on the
exported HighResNPS spreadsheet. All entries were renamed to
[name@item number] to allow identiﬁcations based on analytical
data from multiple entries. All renamed entries were also converted
to.mol ﬁles from their IUPAC name. Retention time was set to
0–13min (the entire run) to allow identiﬁcation from precursor and
fragment ions alone. A master method was then created with the fol-
lowing processing parameters for identiﬁcation: mass error MS1,
3mDa; mass error fragment ions, 3 mDa; and at least one fragment
ion. Retention time and isotopic match were not used as identiﬁca-
tion criteria. The acquired data ﬁles were then processed with the
developed master method.
Bruker data analysis
A library (.csv ﬁle) was created based on the HighResNPS spread-
sheet. All entries were renamed to [name@item number] to allow
identiﬁcations based on analytical data from multiple entries.
Retention time was set to 0–10min (the entire run). Identiﬁcation
was based only on precursor and fragment ions; no retention time
Table II. Experimental setups used in the participating laboratories for the HighResNPS data analysis
Thermo Fisher TraceFinder Waters UNIFI Bruker Data analysis Agilent MassHunter
LC system Dionex Ultimate 3000 HPLC
system (Thermo)
Acquity UPLC I-Class (Waters) Acquity I-Class UPLC system
(Waters)
1290 Inﬁnity II LC system
(Agilent)
LC column Acquity UPLC 1.8 μm HSS C18
(150mm × 2.1 mm)
(Waters)
Acquity UPLC 1.8 μm HSS C18
(150mm × 2.1 mm) (Waters)
Acquity UPLC 1.7 μm BEH
C18, (100mm × 2.1 mm)
(Waters)
Acquity 1.7 μm BEH C18 (50 ×
3.0 mm2) (Waters)
LC gradient Linear gradient of 5–95% B
within 12.5 min.Mobile
phase A: 2 mM ammonium
formate buffer with 0.1%
formic acid (v/v). mobile
phase B: 0.1% formic acid
in methanol (v/v)
Linear gradient of 13–50% B
from 0.5 to 10 min, then
50–95% B from 10 to
10.75 min. Mobile phase A:
5mM aqueous ammonium
formate buffer (pH 3),
mobile phase B: 0.1% formic
acid in acetonitrile (v/v)
Linear gradient of 0–20% B
from 0 to 4 min, then
20–80% B to 8min, constant
80% B to 8.5 min, 80–100%
B to 9min, constant 100% B
to 10min, and
reequilibration at 0% B to
13.5 min. Mobile phase A:
0.1% aqueous formic acid,
mobile phase B: acetonitrile
Linear gradient of 10–50 from
0.5 to 8min, then 50–5% B
from 8 to 10min, constant
for 0.1 min (with concurrent
increase in ﬂow rate to
400 μL/min), 0% B over
0.1 min and maintained for
1.8 min. Mobile phase A:
0.1% aqueous formic acid,
mobile phase B: acetonitrile
Injection volume 1 μL 3 μL 10 μL 0.3 μL
Flow rate 200 μL/min 400 μL/min 600 μL/min 350–400 μL/min
Mass
spectrometer
type
Qq-Orbitrap QqTOF QqTOF QqTOF
Trade name Q-Exactive (Thermo) Xevo G2-S QTof (Waters) maXis Impact QTOF (Bruker) 6545 QTOF (Agilent)
Acquisition
control
DDA (full-scan followed by
MS/MS scan of top-5 signals
with a dynamic exlusion of
5 s. Isolation width: 1 m/z)
DIA (MS scan at low and high
collision energy; intensity
threshold of 200 and 20
counts; deconvolution based
on chromatographic
coelution)
DIA (MS scan at low and high
collision energy)
DDA (full-scan followed by
MS/MS, based on a preferred
precursor mass list then
abundance with two
precursors selected per full
MS. Exclusion for 0.05 min.
Isolation width: 1.3 m/z)
Collision energy NCE: 30 eV LE: 4 eV
HE: ramp from 10 to 40 eV
MS: 4 eV
bbCID: 25 eV
20 eV
Scan range(s) MS 130–600, MS/MS dynamic
ﬁrst mass
50–950 50–1,000 MS: 100–1,000, MS/MS:
40–700
Data analysis
software
TraceFinder Forensic 4.1 UNIFI 1.8.2 Target Analysis (1.3) and Data
Analysis (4.1)
MassHunter Quantitative
Analysis (B.09) and
MassHunter PCDL version
B07
bbCID, Broad-band collision induced dissociation; DDA, data-dependent acquisition; DIA, data-independent acquisition; HE, high energy; LC, liquid chroma-
tography; LE, low energy; MS, mass spectrometry; MS/MS, tandem mass spectrometry; NCE, normalized collision energy.
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or isotopic parameters were used in the identiﬁcation. A master
method was created with the following processing parameters for
identiﬁcation: mass error precursor set to 10 ppm and at least one
fragment ion. The acquired data ﬁles were then processed with the
developed master method.
Agilent MassHunter
HighResNPS data, including drug names, formulae, accurate parent
masses and measured fragment ion masses, were imported into a
Quant method (see Supplementary material for the Python script
and methodology). Nominal retention times were set to 6 ± 6min
(the entire run) and the extracted ion chromatogram width was set
to ±0.02 Thomsons. The method outlier settings were applied as fol-
lows: mass accuracy ±0.005 Thomsons; mass match score (isotopic
pattern) minimum 50%; and qualiﬁer coelution score 50%. After
applying the method to the data ﬁle, the Compounds-At-A-Glance
functionality was used to sort the data by showing only hits that
met the method outlier criteria.
Results and Discussion
A visual representation of the entries in HighResNPS is given in
Figure 3, where the entries are divided into drug classes with infor-
mation on total entries, unique entries and percentage with a mini-
mum of one fragment ion. Synthetic cannabinoids has been the
largest group, as measured by new entries on the European drug
market in the last few years; this pattern is also reﬂected in the
HighResNPS database, where synthetic cannabinoids account for
37% of all classiﬁed entries.
The HighResNPS database currently contains more than 1,700
entries (1,149 unique entries), and 827 have a minimum of one
recorded fragment ion (401 unique entries). Within the group of
entries with a minimum of one fragment ion, 30% have two frag-
ment ions and 59% have three fragment ions.
All 10 NPS in the tested samples were identiﬁed by at least three
of the four instruments as presented in Table III. The researcher
responsible for screening the spiked samples decided the dilution
level and screening settings based on their knowledge of the dynamic
range of their instrument.
Acrylfentanyl and MDMB-CHMICA had multiple entries, with
diagnostic fragment ions in the HighResNPS database and conse-
quently multiple identiﬁcations across all instrument platforms. The
NPS mixture was prepared from drug seizures, so some of the drugs
contained impurities. N-ethylhexedrone was identiﬁed across all
four instrument platforms, and the analytical spectra corresponded
to reference spectra for that compound. However, as N-ethylhexe-
drone was not spiked into the sample, it was considered an impurity
rather than a false positive. The participating laboratories were
requested to use only one diagnostic fragment ion as an identiﬁca-
tion criterion, even when more diagnostic fragment ions were avail-
able to rank positive hits. For this reason, false positive hits were
Figure 3. Entries in the HighResNPS database divided into drug categories. Unshaded bars: Entries with unique InChIKeys, unshaded plus shaded bars: total
entries. Diamonds: % entries with a minimum of one fragment ion within the group.
Table III. List of positive identiﬁcations with the four different
screening workﬂows
NPS Identiﬁed
Deschloro-ketamin 3
Fluoropentedrone 4
3-Methylphenmetrazine 4
2C-B-FLY 3
Adinazolam 3
Acrylfentanyl 4
bk-IVP 4
25C-NBF 3
CUMYL-4CN-BINACA 4
MDMB-CHMICA (MMB-CHMINACA) 4
HighResNPS.com: An Online Crowd-Sourced HR-MS Database 525
D
ow
nloaded from
 https://academ
ic.oup.com
/jat/article-abstract/43/7/520/5490238 by Faculty of Life Sciences Library user on 15 O
ctober 2019
reported, mainly corresponding to isomers of phenethylamine 3-
methylphenmetrazine. The positional isomer 4-methylphenmetrazine
was also identiﬁed across all four instrument platforms from the
same analytical data as 3-methylphenmetrazine. Each compound
has three common fragment ions based on the analytical data avail-
able in HighResNPS. As such, distinguishing them is impossible
without the analytical standards to test chromatographic behavior.
False positives as a result of isomers are an acceptable ﬁnding in the
context of this approach to screening, since, in practice, no com-
pounds would be reported without further investigation and conﬁr-
mation. When structurally related isomers (but not positional
isomers) produce identical precursor ions together with overlapping
fragment ions, additional diagnostic fragment ions must be used.
The isomers 3- and 4-methylphenmetrazine share molecular formu-
las and one fragment ion with the isomer 3-methylethcathinone.
However, the use of the fragment ions 131.0855 and 119.0491, for
3- and 4-methylphenmetrazine and 3-methylcathinone, respectively,
allows the two isomers to be distinguished. Note, however, that the
most abundant fragment ions might not be the most suitable diag-
nostic fragment ions in the HR-MS–MS spectrum for differentiating
among isomers (15). Most post-targeted screening workﬂows
would be aided by either a higher number of fragment ions or addi-
tional identiﬁcation parameters to circumvent this problem. The
identiﬁcation conﬁdence was increased with the observation of mul-
tiple identiﬁcations for the same target, corresponding to multiple
HighResNPS entries.
Notably, a set of prerequisites were made for the screening in
the present study; consequently, the applications presented in
Methods and Experimental are merely illustrative examples of how
to use HighResNPS in a forensic setting. In-silico fragmentation
and isotope matching are often embedded features in modern
screening software aimed at supporting suspect screening. These
features are not fully utilized in the present study, as the aim here
was to provide a comparable screening workﬂow using only
HighResNPS rather than providing a comprehensive report on
four different HR-MS screening workﬂows. Additional applica-
tions of the database could include examining the retention times
from other laboratories using identical chromatographic condi-
tions, or additionally screening for entries without fragment ions
with additional ﬁltering tools to reduce false positive hits, such as
predicted retention times or collision cross section values and/or in
silico fragmentation (16–19).
The strength of using external MS databases in comprehensive
screening strategies has been shown in a number of studies, either as
a stand-alone strategy (16) or in conjunction with a targeted screen-
ing (7). The in-silico ﬁltering tools offer great advantages and pro-
spects for compound identiﬁcation, but the use of diagnostic
fragment ions in MS screening is a great tool to improve identiﬁca-
tion accuracy (16, 18, 20).
Two limitations of HighResNPS.com are the manual data cura-
tion and the lack of peer reviewing. Continuous curation is an
advantage of the commercial databases, which have designated
funds and personnel for this. When a given NPS has multiple analyt-
ical entries in the database, the data self-validate, since different
users with different standards are unlikely to report the same faulty
data. Thus, if a positive hit is obtained after screening with
HighResNPS, the user can further support identiﬁcation by retriev-
ing full HR-MS spectra on mzcloud5 and/or additional information
on NPS Data Hub (13), and ultimately perform an unambiguous
identiﬁcation with an analytical reference standard.
Conclusion
The present work clearly demonstrates that HighResNPS is fully
compatible with screening software from Waters, Thermo Fisher,
Bruker and Agilent, as veriﬁed in this publication. The database can
serve as a useful add-on in LC–HR-MS screening workﬂows, to
help in keeping the screening libraries up-to-date and thereby facili-
tate a more rapid and global response to emerging NPS.
Supplementary data
Supplementary material is available at Journal of Analytical Toxicology
online.
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